Mangoceuticals (MGRX) Other Non-Current Assets (2022 - 2025)

Mangoceuticals has disclosed Other Non-Current Assets across 4 years of filings, most recently posting $16942.0 for Q3 2025.

• Other Non-Current Assets for Q3 2025 came in at $16942.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $16942.0 (changed 0.0% YoY), and the FY2024 annual result was $16942.0, changed 0.0% from the prior year.
• Other Non-Current Assets came in at $16942.0 for Q3 2025 at Mangoceuticals, roughly flat from $16942.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $191183.0 in Q4 2022 to a low of $16942.0 in Q1 2023.
• The 4-year median for Other Non-Current Assets is $16942.0 (2023), against an average of $40194.8.
• Across the five-year window, Other Non-Current Assets slumped 91.14% in 2023 and jumped 618.53% in 2024, its largest moves.
• Mangoceuticals' Other Non-Current Assets stood at $191183.0 in 2022, then plunged by 91.14% to $16942.0 in 2023, then changed by 0.0% to $16942.0 in 2024, then changed by 0.0% to $16942.0 in 2025.
• The last three Other Non-Current Assets figures came in at $16942.0 (Q3 2025), $16942.0 (Q2 2025), and $16942.0 (Q1 2025), per Business Quant data.